The vascular endothelial growth factor family in adverse pregnancy outcomes. (Q34267491)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495259%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

The vascular endothelial growth factor family in adverse pregnancy outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495259%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495259%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

P H Andraweera

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495259%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

G A Dekker

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495259%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

11 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495259%20AND%20SRC:MED&resulttype=core&format=json

Human Reproduction Update

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495259%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495259%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495259%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

436-457

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22495259%20AND%20SRC:MED&resulttype=core&format=json

Low urinary placental growth factor is a marker of pre-eclampsia

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

A single local injection of recombinant VEGF receptor 2 but not of Tie2 inhibits retinal neovascularization in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Association of vascular endothelial growth factor +936 C/T single-nucleotide polymorphism with pregnancies complicated by small-for-gestational-age babies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Early embryonic demise: no evidence of abnormal spiral artery transformation or trophoblast invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Weight in infancy and death from ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Fetal and placental size and risk of hypertension in adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Effects of vascular endothelial growth factor on porcine preimplantation embryos produced by in vitro fertilization and somatic cell nuclear transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Placental oxidative stress: from miscarriage to preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Association of maternal endothelial dysfunction with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

A longitudinal study of biochemical variables in women at risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

The association between small size for gestational age and perinatal and neonatal death in a UK Regional Health Authority.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Structure and function of placental growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Expression of the vascular endothelial growth factor and its receptors and effects of VEGF during in vitro maturation of bovine cumulus-oocyte complexes (COC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

The placenta in preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Epidemiology and causes of preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Decidual NK cells regulate key developmental processes at the human fetal-maternal interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Habitual abortion: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Expression of vascular endothelial growth factor messenger ribonucleic acid and protein in human preimplantation embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Normal placentation: a tale that requires an epithelial-to-endothelial conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Endoglin regulates nitric oxide-dependent vasodilatation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Manifestations of chronic disease during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11–13 Weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Fully Bayesian tests of neutrality using genealogical summary statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Vascular Endothelial Growth Factor Is Increased in Patients With Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Fetal umbilical cord oxygen values and birth to placental weight ratio in relation to size at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Urinary Placental Growth Factor and Risk of Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Defective angiogenesis in mice lacking endoglin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Recurrent miscarriage: aetiology, management and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Cycle dependency of intrauterine vascular endothelial growth factor levels is correlated with decidualization and corpus luteum function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Endothelial growth factor therapy improves preeclampsia-like manifestations in a murine model induced by overexpression of sVEGFR-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

The contribution of low birth weight to infant mortality and childhood morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Glucose tolerance and resistance to insulin-stimulated glucose uptake in men aged 70 years in relation to size at birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Developmental origins of the metabolic syndrome: prediction, plasticity, and programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Characterization of vascular endothelial growth factor (VEGF) in the uterine cervix over pregnancy: effects of denervation and implications for cervical ripening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Vascular endothelial growth factor gene polymorphisms and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Placenta growth factor activates monocytes and correlates with sickle cell disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

First-trimester prediction of hypertensive disorders in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

The discovery of the placental growth factor and its role in angiogenesis: a historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

The preterm labor syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Differential mRNA expression in rabbit in vivo pre-implantatory embryos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

An overview of mortality and sequelae of preterm birth from infancy to adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

First trimester urinary placental growth factor and development of pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Signal transduction to hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

VEGF expression in the placenta from pregnancies complicated by hypertensive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Diagnosis and management of gestational hypertension and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Allelic variations in angiogenic pathway genes are associated with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Soluble fms-like Tyrosine Kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Effect of recombinant placental growth factor 2 on hypertension induced by full-length mouse soluble fms-like tyrosine kinase 1 adenoviral vector in pregnant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

The biology of vascular endothelial growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

The molecular basis of recurrent pregnancy loss: impaired natural embryo selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Expression of vascular endothelial growth factor and placenta growth factor in human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011

Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMS011